Suggestions
Gerald Commissiong
Chief Executive Officer at Amarantus Bioscience Holdings, Inc. and Todos Medical Ltd.
Professional Background
Gerald Commissiong is a highly regarded entrepreneur and innovator in the biotechnology sector, whose career spans several pivotal roles that showcase his commitment to addressing critical health issues through the development of novel therapies and diagnostics. As the Chief Executive Officer of Todos Medical, Gerald is spearheading efforts to combat major health concerns such as COVID-19, pediatric severe burns, blindness, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. Under his leadership, Todos Medical is positioned at the forefront of biotechnological advancements, demonstrating Gerald's unwavering dedication to enhancing patient outcomes.
Gerald's expertise encompasses a wide range of disciplines, allowing him to excel in acquiring and licensing breakthrough technologies. His strategic planning abilities and business acumen have fueled the growth and development of several notable companies within the biotechnology landscape. Specifically, his experience in corporate development has been instrumental in cultivating partnerships that pave the way for innovative research and development initiatives.
Previously, Gerald served as Managing Partner at Fortitude Advisors LLC, where he utilized his extensive knowledge of the market to offer invaluable guidance on business strategies and acquisitions. His tenure as Co-Founder and Chief Business Officer at Amarantus Therapeutics, Inc. marked a significant phase in his career, during which he played a vital role in directing the company's growth trajectory and establishing its reputation in the field of medical biotechnology.
Education and Achievements
Gerald Commissiong laid the foundation for his impressive career with a solid educational background. He attended Saint Michael's College School and Collège Notre-Dame for his high school education before pursuing higher studies at Stanford University, where he earned a Bachelor of Science degree in Management Science and Engineering. This prestigious education equipped Gerald with critical analytical skills and a thorough understanding of engineering principles, which he has effectively applied throughout his career.
In addition to his academic accomplishments, Gerald has garnered recognition for his leadership and contributions to biotechnology. His role at Todos Medical has significantly impacted the medical community, particularly in devising strategies to meet urgent health challenges, demonstrating his capacity as a leader and innovator.
Notable Achievements
Throughout his distinguished career, Gerald has held a variety of key positions in leading organizations. He served as President & CEO and Director at Amarantus BioScience Holdings, Inc., where his vision and strategies led to remarkable advancements in the company’s objectives. As a Board Member at Avant Diagnostics, Inc., Gerald contributed his insights to the governance and strategic direction of the organization.
Gerald’s journey also involved notable roles such as Chief Operating Officer at Amarantus BioSciences, Inc., where he was pivotal in executing operations that supported the company’s mission. As the Founder and CEO of CNS Protein Therapeutics, Inc., he demonstrated exceptional entrepreneurial spirit, leading the organization from its inception to a reputable biotechnology entity. His diverse experience includes consulting and advisory roles, including his position as a Web Consultant at Maxim Integrated Products, which emphasizes his adaptability and wide-ranging skill set.
In addition to his corporate endeavors, Gerald also has a background in athletics, having played for the Calgary Stampeders, showcasing his versatility and determination in various competitive arenas. His commitment to excellence is evident not only in his business pursuits but also in his athletic career.
Achievements
Gerald Commissiong is widely recognized in the biotechnology sector for his strategic initiatives and impactful leadership.
He has instrumentalized partnerships and acquisitions that reinforce the growth trajectories of the companies he has influenced. Gerald's adeptness in corporate development allows him to identify and secure innovative therapies that meet essential medical needs.
